期刊文献+

同源序列对CYP2A13基因SNP研究的影响 被引量:1

Interference of Homologous Sequences on the SNP Study of CYP2A13 Gene
下载PDF
导出
摘要 背景与目的已有研究表明:细胞色素P450酶2A13(cytochrome P4502A13,CYP2A13)在单核苷酸多态性(single nucleotide polymorphisms,SNP)与疾病关联中起重要作用。细胞色素P450酶是一组同工酶,基因序列间有高度的同源性,可能对SNP分析产生影响。本研究初步探讨同源序列对CYP2A13基因SNP研究的影响。方法应用Taqman探针检测573例人群rs8192789位点的分布,采用BLAST方法分析引物结合序列。对60例样本的CYP2A13序列进行测序,进一步进行了TA克隆测序,应用BLAST方法分析了克隆测序结果。结果rs8192789位点在573例人群中只有3例为TT纯合型,其余均为CT杂合型,BLAST分析为同源序列导致。60例人群CYP2A13部分序列测序结果完全一致,有大量套峰,101氨基酸位点处没有dbSNP数据库中报道的SNP位点。克隆测序为247bp、235bp两个片段。结论CYP2A13的同源序列对SNP研究造成了干扰,部分SNP位点可能是不存在的。 Background and objective It has been proven that cytochrome P450 enzyme 2A13 (CYP2A13) played an important role in the association between single nucleotide polymorphisms (SNP) and human diseases.Cytochrome P450 enzymes are a group of isoenzymes,whose sequence homology may interfere with the study for SNP.The aim of this study is to explore the interference on the SNP study of CYP2A13 caused by homologous sequences.Methods Taqman probe was applied to detect distribution of rs8192789 sites in 573 subjects,and BLAST method was used to analyze the amplified sequences.Partial sequences of CYP2A13 were emplified by PCR from 60 cases.The emplified sequences were TA cloned and sequenced.Results For rs8192789 loci in 573 cases,only 3 cases were TT,while the rest were CT heterozygotes,which was caused by homologous sequences.There are a large number of overlapping peaks in identical sequences of 60 cases,and the SNP of 101 amino acid site reported in the SNP database is not found.The cloned sequences are 247 bp,235 bp fragments.Conclusion The homologous sequences may interfere the study for SNP of CYP2A13,and some SNP may not exist.
出处 《中国肺癌杂志》 CAS 2010年第2期94-97,共4页 Chinese Journal of Lung Cancer
基金 国家"十一五"科技攻关项目(No.2006BAI02A01) 国家"863"项目(No.2006AA02401) 天津市科技支撑计划中瑞合作重大项目(No.09ZCZDSF04100)项目资助~~
关键词 细胞色素P450代谢酶2A13 单核苷酸多态性 同源序列 Cytochrome P450 2A13 Single nucleotide polymorphisms Homologous sequences
  • 相关文献

参考文献16

  • 1LiJ, Pan YC, Li YX, et al. Analysis and application of SNP and haplotype in the human genome. Yichuan Xue Bao, 2005, 32(8): 879-889.
  • 2Giacomini KM, Brett CM, Altman RB, et al. The pharmacogenetics research network: from SNP discovery to clinical drug response. Clin Pharmacol Ther, 2007, 81 (3): 328-345.
  • 3Sobrino B, Brion M, Carracedo A. SNPs in forensic genetics:a review on SNP typing methodologies. Forensic Sci Int, 2005,154(2-3): 181-194.
  • 4Suh Y, ViigJ. SNP discovery in associating genetic variation with human disease phenotypes. Mutat Res, 2005, 573(1-2): 41-53.
  • 5Zhang X, D'Agostino J, Wu H, et al. CYP2A13: variable expression and role in human lung microsomal metabolic activation of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. J Pharmacol Exp Ther, 2007, 323(2): 570-578.
  • 6Su T, Bao Z, Zhang Q_Y, et al. Human cytochrome P450 CYP2A13:predomi- nant expression in the respiratory tract and its high efficiency metabolic activation of a tobacco-specific carcinogen,4-(methylnitrosamino)-1-(3- pyridyl)- 1-butanone. Cancer Res, 2000, 60(18): 5074-5079.
  • 7D'Agostino J, Zhang X, Wu H, et al. Characterization of CYPZA13*2, a variant cytochrome P450 allele previously found to be associated with decreased incidences of lung adenocarcinoma in smokers. Drug Metab Dispos, 2008, 36(11): 2316-2323.
  • 8Timofeeva MN, Kropp S, Sauter W, et al. CYP450 polymorphisms as risk factors for early-onset lung cancer: gender-specific differences. Carcinogenesis, 2009, 30(7): 1161-1169.
  • 9Wang H, Tan W, Hao B, et al. Substantial reduction in risk of lung adenocar- cinoma associated with genetic polymorphism in CYP2A13, the most active cytochrome P450 for the metabolic activation of tobacco-specific carcinogen NNK. Cancer Res, 2003, 63 (22): 8057-8061.
  • 10Cauffiez C, Lo-Guidice JM, Q uaranta S, et al. Genetic polymorphism of the human cytochrome CYP2A13 in a French population: implication in lung cancer susceptibility. Biochem Biophys Res Commun, 2004, 317(2): 662-669.

同被引文献8

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部